Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04861792
Other study ID # R18HS027076
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date March 13, 2023

Study information

Verified date March 2023
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Unhealthy alcohol use is a major contributor to morbidity and mortality in the US. Although effective prevention for unhealthy alcohol use and medication treatment for alcohol use disorders (AUDs) can be provided in primary care (PC), they have historically not been included in routine services. As a result, most patients do not receive evidence-based prevention or treatment for unhealthy alcohol use. Several efforts have successfully implemented alcohol-related preventive care-referred to as screening and brief intervention (SBI), but efforts to increase treatment of AUDs with medications have been less successful. Moreover, implementation efforts have usually neglected smaller PC practices, in which most PC is provided. The Michigan SPARC trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, bringing extensive expertise implementing evidence-based alcohol-related care, and Altarum Institute in Ann Arbor, Michigan, bringing demonstrated success engaging over 500 small to medium Michigan-based PC practices in effective quality improvement (QI) efforts. The project builds on Altarum's innovative approach to implementing new or improved clinical care using practice facilitators to provide continuing medical education and maintenance of certification (CME/MOC) programs to PC providers, along with ongoing support for QI using evidence-based implementation strategies. The KPWHRI team recently finished the highly successful AHRQ-funded Sustained Patient-centered Alcohol-Related Care (SPARC) trial using similar implementation strategies in KP Washington, including use of electronic health records and performance monitoring and feedback, and also developed a patient decision aid to support shared decision-making between patients with high-risk drinking and/or AUDs and their PC providers. The Michigan SPARC trial combines Altarum's expertise in QI in small-medium PC practices in Michigan with KPWHRI's expertise implementing evidence-based prevention and treatment of unhealthy alcohol use-specifically alcohol SBI and medication treatment for AUDs. Specific Aims of the Michigan SPARC trial had to be markedly modified due to the trial beginning in March 2020 at the same time as the COVID pandemic. A trial was not possible. The revised aims were to describe alcohol screening, brief intervention, AUD diagnosis and initiation of medication treatment for AUD, before and after the Michigan SPARC model was implemented, in small to medium PC practices in Michigan.


Recruitment information / eligibility

Status Completed
Enrollment 9590
Est. completion date March 13, 2023
Est. primary completion date March 13, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults age 18 years and older - Seen in primary care at a study practice during the practice's study period Exclusion Criteria: • None

Study Design


Intervention

Behavioral:
Michigan SPARC Quality Improvement Intervention
Practice facilitation, electronic health record (EHR) support, performance monitoring and feedback combined with alcohol-related continuing medical education (CME) and maintenance of certification (MOC) and tools to support alcohol related care including a decision aid for shared decision making about alcohol use disorder (AUD).

Locations

Country Name City State
United States Altarum Institute Ann Arbor Michigan

Sponsors (4)

Lead Sponsor Collaborator
Kaiser Permanente Agency for Healthcare Research and Quality (AHRQ) - Funder, Altarum Institute, NORC at the University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevention - Screening and brief intervention The proportion of PC patients who screen positive for unhealthy alcohol use and have BI documented in their EHR. For Aim 1 the period up to 6 months before the launch date will be compared to the 6 month period after the launch date.
Primary Treatment - Prescription of AUD medications The proportion of PC patients who are diagnosed with AUD at a visit who also receive a prescription for medications to treat AUD and are seen for follow-up within 14 days. For Aim 1 the period up to 6 months before the launch date will be compared to the 6 month period after the launch date.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04927364 - Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder N/A
Active, not recruiting NCT04618653 - Comprehensive Process Model of AA-related Behavior Change
Recruiting NCT05471154 - Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders N/A
Completed NCT05021640 - Study of DCR-AUD in Healthy Volunteers Phase 1
Not yet recruiting NCT05064228 - Mobile Rewarding Activity Centered Treatment N/A
Completed NCT04958655 - Mental Imagery Intervention for Alcohol Craving N/A
Completed NCT05252221 - Alcohol Telemedicine Consultation in Primary Care (ATC) N/A
Completed NCT06108115 - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder N/A
Not yet recruiting NCT06303778 - Combining a Smartphone App With Medications to Manage Heavy Drinking N/A
Completed NCT04639895 - Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment. N/A
Completed NCT02911285 - NAC for Treating Comorbid PTSD and SUD Phase 2
Recruiting NCT04598399 - Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder N/A
Completed NCT04827056 - Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Phase 1
Completed NCT04974645 - Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use N/A
Recruiting NCT05992272 - Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
Completed NCT04229095 - Medication Development in Alcoholism: Suvorexant Versus Placebo Phase 2
Recruiting NCT05534568 - The Oklahoma Parent-Child Assistance Program N/A
Completed NCT04925570 - The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use Phase 2
Active, not recruiting NCT05492942 - Records for Alcohol Care Enhancement N/A
Recruiting NCT05015881 - Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder Phase 2/Phase 3